Table 1 Clinical characteristics, lung function values and FeNO of the patients included in the study
All asthmatic patients (n = 300) | AA (n = 150) | NA (n = 150) | |
|---|---|---|---|
Family history of atopy (%)* | 120 (40.0 %) | 74 (49.3 %) | 46 (30.7 %) |
Atopic dermatitis (%)* | 15 (5.0 %) | 14 (9.3 %) | 1 (0.7 %) |
Contact dermatitis n (%) | 73 (24.3 %) | 34 (22.7 %) | 39 (26.0 %) |
Food allergy (%)* | 32 (10.7 %) | 28 (18.7 %) | 4 (2.7 %) |
Drug allergy (%)* | 58 (19.3 %) | 19 (12.7 %) | 39 (26.0 %) |
Hypersensitivity to NSAID (%)* | 34 (11.3 %) | 6 (4.0 %) | 28 (18.7 %) |
Psoriasis (%) | 4 (1.3 %) | 2 (1.3 %) | 2 (1.3 %) |
Ichthyosis vulgaris (%) | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) |
Lung function values mean ± SD | |||
FVC (%)* | 97.2 ± 16.0 | 100.9 ± 13.0 | 93.6 ± 17.9 |
FEV1 (%)* | 93.0 ± 17.5 | 96.4 ± 14.2 | 89.7 ± 20.0 |
FEV1/FVC* | 74.7 ± 8.6 | 76.3 ± 8.0 | 73.0 ± 8.8 |
Post-bronchodilator FEV1 improvement (%) | 12.81 ± 9.2 | 12.56 ± 8.5 | 13.1 ± 9.8 |
PEF (%)* | 95.0 ± 20.7 | 99.7 ± 18.2 | 90.3 ± 22.0 |
MMEF (%)* | 63.4 ± 25.7 | 69.8 ± 21.1 | 57.1 ± 28.3 |
FeNO (ppb) mean ± SD* | 32.3 ± 30.8 | 38.0 ± 35.3 | 26.6 ± 24.2 |